We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
101
Lockheed Martin
LMT
$131B
$15.9M 0.16%
34,049
-14,165
-29% -$6.55M
BSX icon
102
Boston Scientific
BSX
$67.6B
$15.7M 0.16%
204,211
-4,869
-2% -$356K
MCK icon
103
McKesson
MCK
$104B
$15.6M 0.16%
26,637
+3,600
+16% +$2M
SHW icon
104
Sherwin-Williams
SHW
$83.8B
$15.5M 0.16%
51,791
+1,527
+3% +$472K
ADI icon
105
Analog Devices
ADI
$181B
$15.5M 0.16%
67,708
-1,425
-2% -$304K
ABNB icon
106
Airbnb
ABNB
$109B
$15.4M 0.16%
101,522
+2,734
+3% +$418K
BA icon
107
Boeing
BA
$166B
$15.2M 0.16%
83,351
+2,376
+3% +$424K
ORLY icon
108
O'Reilly Automotive
ORLY
$71.1B
$15.1M 0.15%
215,025
+900
+0.4% +$62.2K
APH icon
109
Amphenol
APH
$199B
$15.1M 0.15%
224,462
+10,996
+5% +$694K
MDT icon
110
Medtronic
MDT
$115B
$14.5M 0.15%
184,660
-3,982
-2% -$326K
PLD icon
111
Prologis
PLD
$135B
$14.5M 0.15%
128,768
-2,475
-2% -$274K
CTAS icon
112
Cintas
CTAS
$81.7B
$14.4M 0.15%
82,132
+2,232
+3% +$381K
CB icon
113
Chubb
CB
$131B
$14.3M 0.15%
56,138
-1,411
-2% -$362K
COR icon
114
Cencora
COR
$61.3B
$14.3M 0.15%
63,424
+505
+0.8% +$117K
CI icon
115
Cigna
CI
$73.4B
$14.1M 0.14%
42,697
-1,753
-4% -$604K
UPS icon
116
United Parcel Service
UPS
$89.9B
$13.7M 0.14%
100,207
-18,311
-15% -$2.62M
DE icon
117
Deere & Co
DE
$168B
$13.7M 0.14%
36,651
-24,500
-40% -$9.56M
GILD icon
118
Gilead Sciences
GILD
$185B
$13.4M 0.14%
194,941
-1,000
-0.5% -$66.7K
TT icon
119
Trane Technologies
TT
$100B
$13.3M 0.14%
40,446
-6,504
-14% -$2.07M
AZO icon
120
AutoZone
AZO
$47.9B
$13.2M 0.13%
4,447
+74
+2% +$217K
BMY icon
121
Bristol-Myers Squibb
BMY
$137B
$13.2M 0.13%
317,381
+25,543
+9% +$1.14M
ECL icon
122
Ecolab
ECL
$80.1B
$13M 0.13%
54,755
+2,323
+4% +$537K
MDLZ icon
123
Mondelez International
MDLZ
$79.7B
$12.4M 0.13%
189,070
-10,304
-5% -$707K
TMUS icon
124
T-Mobile US
TMUS
$191B
$12.3M 0.13%
70,018
-128
-0.2% -$21.5K
FDX icon
125
FedEx
FDX
$78.4B
$12.3M 0.13%
40,857
-839
-2% -$219K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.